Drexler, Richard http://orcid.org/0000-0002-4830-3671
Khatri, Robin
Schüller, Ulrich
Eckhardt, Alicia
Ryba, Alice
Sauvigny, Thomas
Dührsen, Lasse
Mohme, Malte
Ricklefs, Tammo
Bode, Helena
Hausmann, Fabian
Huber, Tobias B.
Bonn, Stefan
Voß, Hannah
Neumann, Julia E.
Silverbush, Dana
Hovestadt, Volker
Suvà, Mario L.
Lamszus, Katrin
Gempt, Jens
Westphal, Manfred
Heiland, Dieter H.
Hänzelmann, Sonja
Ricklefs, Franz L.
Funding for this research was provided by:
Fördergemeinschaft Kinderkrebs-Zentrum Hamburg
Illumina
HORIZON EUROPE Excellent Science
Deutsche Forschungsgemeinschaft (SFB 1192 B8, SFB 1192 B8, SFB 1192 C3)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 14 September 2023
Revised: 8 December 2023
Accepted: 24 December 2023
First Online: 20 January 2024
Declarations
:
: M.L.S. is equity holder, scientific co-founder and advisory board member of Immunitas Therapeutics.